NEW YORK, Sept. 28, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP alerts investors in Park Ha Biological Technology Co., Ltd. (NASDAQ:BYAH) of a pending securities class action on behalf of purchasers of BYAH
NEW YORK, Sept. 24, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Park Ha Biological Technology Co., Ltd. ("Park Ha" or the "Company") (NASDAQ:BYAH).
Why: Rosen Law Firm, a global investor rights law firm, reminds investors about a class action lawsuit on behalf of purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ:PHH, BYAH)) between
New York, New York--(Newsfile Corp. - September 24, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ:PHH) (NASDAQ:BYAH)
BYAH CFO Xiaoyan Zhu since 2016 signed the December 2024 registration statement that the lawsuit contends omitted the promotional scheme behind BYAH's 93% stock collapse.NEW YORK, Sept. 24, 2026 /PRNewswire/ --
A securities class action traces a seven-month sequence from Park Ha Biological Technology Co., Ltd.'s December 2024 public debut at $4.00 per share to its July 2025 surge above $41.49, followed by a 93%
NEW YORK, Sept. 22, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Park Ha Biological Technology Co., Ltd. ("Park Ha" or the "Company")
New York, New York--(Newsfile Corp. - September 22, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ:PHH) (NASDAQ:BYAH)
NEW YORK, Sept. 22, 2026 (GLOBE NEWSWIRE) -- SueWallSt alerts investors in Park Ha Biological Technology Co., Ltd. (NASDAQ:BYAH) that a securities class action has been filed on behalf of shareholders who purchased
NEW YORK, Sept. 21, 2026 /PRNewswire/ --
Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Park Ha Biological
New York, New York--(Newsfile Corp. - September 21, 2026) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Park Ha Biological Technology Co., Ltd. (NASDAQ:PHH) (NASDAQ:BYAH)
Sections 11 and 12 of the Securities Act are at the center of allegations that Park Ha's December 2024 registration statement omitted that its 1,200,000-share, sub-5% public float was structured to enable a
Three Park Ha Biological Technology Co., Ltd. insiders who signed the December 2024 registration statement are named as individual defendants, and the lawsuit contends their control over BYAH's disclosures left
NEW YORK, Sept. 15, 2026 (GLOBE NEWSWIRE) -- SueWallSt reminds purchasers of Park Ha Biological Technology Co., Ltd. (NASDAQ:BYAH) securities that a class action was filed on behalf of investors who acquired shares
NEW YORK, Sept. 14, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies institutional investors in Park Ha Biological Technology Co., Ltd. (NASDAQ:BYAH) that a class action has been filed on behalf of